Global Journal of Cancer Therapy


Editorial

 

Novel Strategies to Improve Rituximab Efficacy in Non-Hodgkin's Lymphomas

 

Non-Hodgkin's lymphomas (NHLs) are the second fastest growing cancer in terms of incidence and deaths in the United States and Europe. NHLs are a heterogeneous cancer group including several haematological neoplasias with different degree of aggressiveness. In spite of the progresses, conventional therapies do not ensure long-term survival [1].

http://www.peertechz.com/Cancer-Therapy/GJCT-1-102.php

Comments

Popular posts from this blog

Peertechz is not Predatory Open Access Publisher

The prevention and cure research of emergency intervention therapy of balloon occlusion of LAD occurring reperfusion arrhythmia

Case Report: Reynolds Syndrome